Citadel Advisors’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Hold |
|
|||||
|
2025
Q1 | $3.85M | Sell |
|
|||||
|
2024
Q4 | $12.8M | Sell |
|
|||||
|
2024
Q3 | $15M | Buy |
|
|||||
|
2024
Q2 | $12.3M | Buy |
|
|||||
|
2024
Q1 | $12M | Buy |
|
|||||
|
2023
Q4 | $8.12M | Sell |
|
|||||
|
2023
Q3 | $15.8M | Buy |
|
|||||
|
2023
Q2 | $21.4M | Buy |
|
|||||
|
2023
Q1 | $20.1M | Buy |
|
|||||
|
2022
Q4 | $18.2M | Buy |
|